Facebook Linkedin RSS Twitter Youtube
Home 2024

Moderna

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA
GEN Edge

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

Entos Expands In-House Manufacturing with GMP Facility
Bioprocessing

Entos Expands In-House Manufacturing with GMP Facility

Moderna Reports Phase I/II Data for Propionic Acidemia mRNA Therapy
Drug Discovery

Moderna Reports Phase I/II Data for Propionic Acidemia mRNA Therapy

Digital In Vitro Transcription Models Could Aid mRNA Manufacturing
Bioprocessing

Digital In Vitro Transcription Models Could Aid mRNA Manufacturing

StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates
Drug Discovery

StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates

Vaccines in Development
Infectious Diseases

Vaccines in Development

Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases
Bioprocessing

Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases

Rare Disease Day: Moderna Gets Back to Its Roots
Drug Discovery

Rare Disease Day: Moderna Gets Back to Its Roots

GSK and Elegen Team Up to Develop DNA-Based Medicines and Vaccines
Bioprocessing

GSK and Elegen Team Up to Develop DNA-Based Medicines and Vaccines

Launch of Tome Biosciences, AI scientist, mRNA vaccines
Artificial Intelligence

Launch of Tome Biosciences, AI scientist, mRNA vaccines

123...9Page 1 of 9
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.